Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tammenoms Bakker Juliet
Relationship:  
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   10    
Direct Shares   190,546    

Indirect Shares

   34,191,873      
Direct Value   $6,371,625    

Indirect Value

   $650,206,579      
Total Shares   34,382,419      
Total Value   $656,578,203      


Corcept Therapeutics Inc $3,751,111 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $236,425 Eargo, Inc. $0 Rxsight, Inc. $1,809,796 Corcept Therapeutics Inc $3,751,111 Aimmune Therapeutics, Inc. $574,293 Axonics Modulation Technologies, Inc. $236,425 Eargo, Inc. $0 Rxsight, Inc. $1,809,796
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    5   
    13    

     Stock price went up :
    3   
    12    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   1.5   
   12.0   
     Percentage Gain/Loss :
   10.4%
 1,186.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Corcept Therapeutics Inc CORT 10% Owner 2016-12-15 133,539 2016-12-15 10,956,002    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-11-18 28,186    Premium*  
            Aimmune Therapeutics, Inc. AIMT 10% Owner 2018-02-22 16,651 2018-02-22 6,013,134    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2018-09-21 0 2020-08-28 3,202,530    Premium*  
            Axonics Modulation Technologies,... AXNX Director 2020-09-18 3,500 2020-09-18 1,956,359    Premium*  
            Venus Concept Inc VERO Director, 10% Owner 2019-11-07 0 2019-11-07 3,666,119    Premium*  
            Eargo, Inc. EAR Director, 10% Owner 2021-05-17 7,016 2021-05-17 3,008    Premium*  
            Tourmaline Bio TRML 10% Owner 2021-05-11 0 2021-05-11 3,220,775    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Rxsight, Inc. RXST 2024-02-14 29,840 2024-02-14 1,548    Premium*  
* Premium Members only  

Records found :    96         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EAR Eargo, Inc. Director   –       •       •   2020-10-20 4 B $18.00 $4,199,994 I/I 233,333 3,918,691 2.25 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 A $0.00 $0 D/D 3,508 3,508 0 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 A $0.00 $0 I/I 1,504 1,504 0 -
EAR Eargo, Inc. Director   –       •       •   2021-04-14 4 AS $0.00 $0 I/I (1,000,000) 2,918,691 0 -
TRML Tourmaline Bio 10% Owner   –       –       •   2021-05-11 4 A $0.00 $0 I/I 2,985,775 2,985,775 0 -
TRML Tourmaline Bio 10% Owner   –       –       •   2021-05-11 4 B $17.00 $3,995,000 I/I 235,000 3,220,775 1.5 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 A $0.00 $0 D/D 3,508 7,016 0 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 D $0.00 $0 I/I (1,000,000) 1,918,691 0 -
EAR Eargo, Inc. Director   –       •       •   2021-05-17 4 A $0.00 $0 I/I 1,504 3,008 0 -
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2021-05-18 4 B $11.00 $9,999,990 I/I 909,090 3,096,594 1.5 -
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2021-05-18 4 A $0.00 $0 I/I 2,187,504 2,187,504 0 -
RXST Rxsight, Inc. Director   –       •      –    2021-07-30 4 A $0.00 $0 D/D 5,859 5,859 0 -
RXST Rxsight, Inc. Director   –       •      –    2021-08-03 4 B $16.00 $10,000,000 I/I 625,000 500,000 2.1 %
RXST Rxsight, Inc. Director   –       •      –    2021-08-03 4 A $0.00 $0 I/I 1,863,613 1,863,613 0 -
RXST Rxsight, Inc. Director   –       •      –    2021-08-03 4 B $16.00 $200,000 D/D 12,500 18,359 2.39 %
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2022-02-10 4 B $15.00 $4,999,995 I/I 333,333 3,429,927 1.5 -
RXST Rxsight, Inc. Director   –       •      –    2022-06-02 4 A $0.00 $0 D/D 10,349 28,708 0 -
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2023-02-06 4 B $7.00 $11,999,995 I/I 1,714,285 1,714,285 1.5 -
RXST Rxsight, Inc. Director   –       •      –    2023-02-10 4 B $12.50 $6,000,000 I/I 480,000 980,000 2.1 %
RXST Rxsight, Inc. Director   –       •      –    2023-05-26 4 D $0.00 $0 I/I (497,150) 1,491,463 0 -
RXST Rxsight, Inc. Director   –       •      –    2023-05-26 4 A $0.00 $0 D/D 33,135 61,843 0 -
RXST Rxsight, Inc. Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 5,731 67,574 0 -
RXST Rxsight, Inc. Director   –       •      –    2023-06-14 4 D $0.00 $0 I/I (267,300) 712,700 0 -
RXST Rxsight, Inc. Director   –       •      –    2023-06-14 4 A $0.00 $0 D/D 1,022 68,596 0 -
RXST Rxsight, Inc. Director   –       •      –    2023-06-14 4 A $0.00 $0 I/I 439 439 0 -
  96  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us